Page 1 | Search Results | The Journal of Immunology | American Association of Immunologists

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells

Stephen Man, James E. Redman, Deborah L. Cross, David K. Cole, Ilona Can, Bethan Davies, Shaikh Shimaz Hashimdeen, Reiss Reid, Sian Llewellyn-Lacey, Kelly L. Miners, Kristin Ladell, Anya Lissina, Paul E. Brown, Linda Wooldridge, David A. Price, Pierre J. Rizkallah

J Immunol (2021) 207 (4): 1009–1017.

https://doi.org/10.4049/jimmunol.2000756

Published: 15 August 2021

View article titled, Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Autoreactive CD8⁺ T-cells are highly dependent on CD8 for activation and as such targeting CD8 is an effective way of blocking autoreactive CD8⁺ T-cell activation

J Immunol (2017) 198 (1_Supplement): 127.26.

https://doi.org/10.4049/jimmunol.198.Supp.127.26

Published: 01 May 2017

View article titled, Autoreactive CD8+ T-cells are highly dependent on CD8 for activation and as such targeting CD8 is an effective way of blocking autoreactive CD8+ T-cell activation

Add to Citation Manager

Journal Articles

Development of new immune reagents for swine health, vaccine and disease studies

Jean Nepomuscene Manirarora, Michael Bailey, Gourapura Renukaradhya, Scott Kenney, Joanna LaBresh, Yongming Sang, Ore Francis, Linda Wooldridge, Joan Lunney

J Immunol (2017) 198 (1_Supplement): 226.12.

https://doi.org/10.4049/jimmunol.198.Supp.226.12

Published: 01 May 2017

View article titled, Development of new immune reagents for swine health, vaccine and disease studies

Add to Citation Manager

Journal Articles

Epitope Specificity Delimits the Functional Capabilities of Vaccine-Induced CD8 T Cell Populations

Brenna J. Hill, Patricia A. Darrah, Zachary Ende, David R. Ambrozak, Kylie M. Quinn, Sam Darko, Emma Gostick, Linda Wooldridge, Hugo A. van den Berg, Vanessa Venturi, Martin Larsen, Miles P. Davenport, Robert A. Seder, David A. Price, Daniel C. Douek

J Immunol (2014) 193 (11): 5626–5636.

https://doi.org/10.4049/jimmunol.1401017

Published: 01 December 2014

View article titled, Epitope Specificity Delimits the Functional Capabilities of Vaccine-Induced CD8 T Cell Populations

Add to Citation Manager

Includes: Supplementary data

Journal Articles

The length of the peptide in the MHC groove compartmentalizes the CD8+ T cell repertoire (P1186)

John Miles, Hugo van den Berg, Julia Ekeruche-Makinde, Ania Skowera, David Cole, Garry Dolton, Andrea Schauenburg, Mai Ping Tan, Johanne Pentier, Mark Peakman, David Price, Scott Burrows, Andrew Sewell, Linda Wooldridge

J Immunol (2013) 190 (1_Supplement): 190.18.

https://doi.org/10.4049/jimmunol.190.Supp.190.18

Published: 01 May 2013

View article titled, The length of the peptide in the MHC groove compartmentalizes the CD8+ T cell repertoire (P1186)

Add to Citation Manager

Journal Articles

Anti-CD8 Antibodies Can Trigger CD8⁺ T Cell Effector Function in the Absence of TCR Engagement and Improve Peptide–MHCI Tetramer Staining

Mathew Clement, Kristin Ladell, Julia Ekeruche-Makinde, John J. Miles, Emily S. J. Edwards, Garry Dolton, Tamsin Williams, Andrea J. A. Schauenburg, David K. Cole, Sarah N. Lauder, Awen M. Gallimore, Andrew J. Godkin, Scott R. Burrows, David A. Price, Andrew K. Sewell, Linda Wooldridge

J Immunol (2011) 187 (2): 654–663.

https://doi.org/10.4049/jimmunol.1003941

Published: 15 July 2011

View article titled, Anti-CD8 Antibodies Can Trigger CD8+ T Cell Effector Function in the Absence of TCR Engagement and Improve Peptide–MHCI Tetramer Staining

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Anti-CD8 antibodies can trigger T-cell effector function in the absence of TCR engagement and improve pMHCI tetramer staining (113.28)

Linda Wooldridge, Kristin Ladell, David Price, Andrew Sewell, Mathew Clement

J Immunol (2011) 186 (1_Supplement): 113.28.

https://doi.org/10.4049/jimmunol.186.Supp.113.28

Published: 01 April 2011

View article titled, Anti-CD8 antibodies can trigger T-cell effector function in the absence of TCR engagement and improve pMHCI tetramer staining (113.28)

Add to Citation Manager

Journal Articles

Combinatorial peptide library scans of multiple HLA A*0201 restricted CTL reveal high levels of degeneracy at MHCI anchor positions (100.12)

Linda Wooldridge, Emily Edwards, Julia Ekeruche, John Miles, Hugo van den Berg, Mathew Clement, Andrew Sewell

J Immunol (2011) 186 (1_Supplement): 100.12.

https://doi.org/10.4049/jimmunol.186.Supp.100.12

Published: 01 April 2011

View article titled, Combinatorial peptide library scans of multiple HLA A*0201 restricted CTL reveal high levels of degeneracy at MHCI anchor positions (100.12)

Add to Citation Manager

Journal Articles

CD8 Controls T Cell Cross-Reactivity

Linda Wooldridge, Bruno Laugel, Julia Ekeruche, Mathew Clement, Hugo A. van den Berg, David A. Price, Andrew K. Sewell

J Immunol (2010) 185 (8): 4625–4632.

https://doi.org/10.4049/jimmunol.1001480

Published: 15 October 2010

View article titled, CD8 Controls T Cell Cross-Reactivity

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition

David K. Cole, Emily S. J. Edwards, Katherine K. Wynn, Mathew Clement, John J. Miles, Kristin Ladell, Julia Ekeruche, Emma Gostick, Katherine J. Adams, Ania Skowera, Mark Peakman, Linda Wooldridge, David A. Price, Andrew K. Sewell

J Immunol (2010) 185 (4): 2600–2610.

https://doi.org/10.4049/jimmunol.1000629

Published: 15 August 2010

View article titled, Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition

Add to Citation Manager

Journal Articles

MHC Class I Molecules with Superenhanced CD8 Binding Properties Bypass the Requirement for Cognate TCR Recognition and Nonspecifically Activate CTLs

Linda Wooldridge, Mathew Clement, Anna Lissina, Emily S. J. Edwards, Kristin Ladell, Julia Ekeruche, Rachel E. Hewitt, Bruno Laugel, Emma Gostick, David K. Cole, Reno Debets, Cor Berrevoets, John J. Miles, Scott R. Burrows, David A. Price, Andrew K. Sewell

J Immunol (2010) 184 (7): 3357–3366.

https://doi.org/10.4049/jimmunol.0902398

Published: 01 April 2010

View article titled, MHC Class I Molecules with Superenhanced CD8 Binding Properties Bypass the Requirement for Cognate TCR Recognition and Nonspecifically Activate CTLs

Add to Citation Manager

Journal Articles

Ca²⁺ Release from the Endoplasmic Reticulum of NY-ESO-1–Specific T Cells Is Modulated by the Affinity of TCR and by the Use of the CD8 Coreceptor

Ji-Li Chen, Anthony J. Morgan, Guillaume Stewart-Jones, Dawn Shepherd, Giovanna Bossi, Linda Wooldridge, Sarah L. Hutchinson, Andrew K. Sewell, Gillian M. Griffiths, P. Anton van der Merwe, E. Yvonne Jones, Antony Galione, Vincenzo Cerundolo

J Immunol (2010) 184 (4): 1829–1839.

https://doi.org/10.4049/jimmunol.0902103

Published: 06 January 2010

View article titled, Ca2+ Release from the Endoplasmic Reticulum of NY-ESO-1–Specific T Cells Is Modulated by the Affinity of TCR and by the Use of the CD8 Coreceptor

Add to Citation Manager

Includes: Multimedia, Supplementary data

Journal Articles

Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface

Linda Wooldridge, Sarah L. Hutchinson, Ed M. Choi, Anna Lissina, Emma Jones, Fareed Mirza, P. Rod Dunbar, David A. Price, Vincenzo Cerundolo, Andy K. Sewell

J Immunol (2003) 171 (12): 6650–6660.

https://doi.org/10.4049/jimmunol.171.12.6650

Published: 15 December 2003

View article titled, Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface

Add to Citation Manager

Journal Articles

High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining

Ed Man-Lik Choi, Ji-Li Chen, Linda Wooldridge, Mariolina Salio, Anna Lissina, Nikolai Lissin, Ian F. Hermans, Jonathan D. Silk, Fareed Mirza, Michael J. Palmowski, P. Rod Dunbar, Bent K. Jakobsen, Andy K. Sewell, Vincenzo Cerundolo

J Immunol (2003) 171 (10): 5116–5123.

https://doi.org/10.4049/jimmunol.171.10.5116

Published: 15 November 2003

View article titled, High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining

Add to Citation Manager

NARROW

Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells

Autoreactive CD8⁺ T-cells are highly dependent on CD8 for activation and as such targeting CD8 is an effective way of blocking autoreactive CD8⁺ T-cell activation

Development of new immune reagents for swine health, vaccine and disease studies

Epitope Specificity Delimits the Functional Capabilities of Vaccine-Induced CD8 T Cell Populations

The length of the peptide in the MHC groove compartmentalizes the CD8+ T cell repertoire (P1186)

Anti-CD8 Antibodies Can Trigger CD8⁺ T Cell Effector Function in the Absence of TCR Engagement and Improve Peptide–MHCI Tetramer Staining

Anti-CD8 antibodies can trigger T-cell effector function in the absence of TCR engagement and improve pMHCI tetramer staining (113.28)

Combinatorial peptide library scans of multiple HLA A*0201 restricted CTL reveal high levels of degeneracy at MHCI anchor positions (100.12)

CD8 Controls T Cell Cross-Reactivity

Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition

MHC Class I Molecules with Superenhanced CD8 Binding Properties Bypass the Requirement for Cognate TCR Recognition and Nonspecifically Activate CTLs

Ca²⁺ Release from the Endoplasmic Reticulum of NY-ESO-1–Specific T Cells Is Modulated by the Affinity of TCR and by the Use of the CD8 Coreceptor

Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface

High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only